How has PhaseBio Pharmaceuticals, Inc.'s stock price performed over the past year?

Question

Accepted Answer

PhaseBio Pharmaceuticals, Inc.'s stock has declined approximately -95.26351% over the past 52 weeks. The 50-day moving average sits at 0.43, while the 200-day moving average is 0.91.

Beta (5Y)	N/A
52-Week Price Change	-95.26351%
50-Day Moving Average	0.43
200-Day Moving Average	0.91
Average Volume (20 Days)	N/A

PhaseBio Pharmaceuticals, Inc.

Stock Price Statistics